Detection of circulating tumor cells in high-risk endometrial cancer

Anticancer Research

Volumn 35, Issue 2, 2015, Pages 683-687

  Bogani, Giorgio ^a   Liu, Minetta C ^a   Dowdy, Sean C ^a   Cliby, William A ^a   Kerr, Sarah E ^a   Kalli, Kimberly R ^a   Kipp, Benjamin R ^a   Halling, Kevin C ^a   Campion, Michael B ^a   Mariani, Andrea ^a  

^a MAYO CLINIC   (United States)

Author keywords

Circulating tumor cells; Endometrial cancer; Hematogenous dissemination; Prognosis; Recurrence

Indexed keywords

AGED; BLOOD; ENDOMETRIUM TUMOR; FEMALE; HUMAN; IMMUNOMAGNETIC SEPARATION; MIDDLE AGED; PATHOLOGY; TUMOR EMBOLISM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOMAGNETIC SEPARATION; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING;

EID: 84923676062     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics. CA Cancer J Clin 64: 9-29, 2014.
2. Mariani A, Webb MJ, Keeney GL, Lesnick TG and Podratz KC: Surgical stage I endometrial cancer: predictors of distant failure and death. Gynecol Oncol 87: 274-280, 2002.
3. Mariani A, Webb MJ, Keeney GL, Calori G and Podratz KC: Hematogenous dissemination in corpus cancer. Gynecol Oncol 80: 233-238, 2001.
4. AlHilli MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree ME, Kumar S, Keeney GL, Cliby WA and Mariani A: Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Gynecol Oncol 128: 294-299, 2013.
5. Pantel K, Brakenhoff RH: Dissecting the metastatic cascade. Nat Rev Cancer 4: 448-56, 2004.
6. Ligthart ST, Coumans FA, Bidard FC, Simkens LH, Punt CJ, de Groot MR, Attard G, de Bono JS, Pierga JY and Terstappen LW: Circulating tumor cells count and morphological features in breast, colorectal and prostate cancer. PLoS One 8: e67148, 2013.
7. Liu MC, Shields PG, Warren RD, Cohen P, Wilkinson M, Ottaviano YL, Rao SB, Eng-Wong J, Seillier-Moiseiwitsch F, Noone AM and Isaacs C: Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer. J Clin Oncol 27: 5153-5159, 2009.
8. Thalgott M, Rack B, Maurer T, Souvatzoglou M, Eiber M, Kreß V, Heck MM, Andergassen U, Nawroth R, Gschwend JE and Retz M: Detection of circulating tumor cells in different stages of prostate cancer. J Cancer Res Clin Oncol 139: 755-763, 2013.
9. Fehm T, Becker S, Bachmann C, Beck V, Gebauer G, Banys M, Wallwiener D and Solomayer EF: Detection of disseminated tumor cells in patients with gynecological cancers. Gynecol Oncol 103: 942-947, 2006.
10. Banys M, Solomayer EF, Becker S, Krawczyk N, Gardanis K, Staebler A, Neubauer H, Wallwiener D and Fehm T: Disseminated tumor cells in bone marrow may affect prognosis of patients with gynecologic malignancies. Int J Gynecol Cancer 19: 948-952, 2009.
11. Klein A, Fishman A, Zemer R, Zimlichman S and Altaras MM: Detection of tumor circulating cells by cytokeratin 20 in the blood of patients with endometrial carcinoma. Gynecol Oncol 78: 352-355, 2000.
12. Ji XQ, Sato H, Tanaka H, Konishi Y, Fujimoto T, Takahashi O and Tanaka T: Real-time quantitative RT-PCR detection of disseminated endometrial tumor cells in peripheral blood and lymph nodes using the LightCycler System. Gynecol Oncol 100: 355-360, 2006.
13. Obermayr E, Sanchez-Cabo F, Tea MK, Singer CF, Krainer M, Fischer MB, Sehouli J, Reinthaller A, Horvat R, Heinze G, Tong D and Zeillinger R: Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients. BMC Cancer 10: 666, 2010.
14. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG and Wilkinson EJ: Histological typing of female genital tract tumours. Berlin. Springer-Verlag; 1994.
15. Creasman WT, Odicino F, Maisonneuve P, Beller U, Benedet JL, Heintz AP, Ngan HY, Sideri M and Pecorelli S: Carcinoma of the corpus uteri. J Epidemiol Biostat 6: 47-86, 2001.
16. Bogani G, Dowdy SC, Cliby WA, Ghezzi F, Rossetti D and Mariani A: Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence. J Obstet Gynaecol Res 40: 301-311, 2014.
17. Mariani A, Dowdy SC, Keeney GL, Long HJ, Lesnick TG and Podratz KC: High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy. Gynecol Oncol 95: 120-126, 2004.
18. Food and Drug Administration, HHS: Medical devices; immunology and microbiology devices; classification of the immunomagnetic circulating cancer cell selection and enumeration system. Final rule. Fed Regist 69: 26036-26038, 2004.
19. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW and Terstappen LW: Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10: 6897-6904, 2004.
20. Zhong XY, Kaul S, Eichler A and Bastert G: Evaluating GA733-2 mRNA as a marker for the detection of micrometastatic breast cancer in peripheral blood and bone marrow. Arch Gynecol Obstet 263: 2-6, 1999.
21. Obermayr E, Castillo-Tong DC, Pils D, Speiser P, Braicu I, Van Gorp T, Mahner S, Sehouli J, Vergote I and Zeillinger R: Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance: a study of the OVCAD consortium. Gynecol Oncol 128: 15-21, 2013.
22. Stott SL, Hsu CH, Tsukrov DI, Yu M, Miyamoto DT, Waltman BA, Rothenberg SM, Shah AM, Smas ME, Korir GK, Floyd FP Jr, Gilman AJ, Lord JB, Winokur D, Springer S, Irimia D, Nagrath S, Sequist LV, Lee RJ, Isselbacher KJ, Maheswaran S, Haber DA and Toner M: Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci USA 107: 18392-18397, 2010.